N,N＇-二（2-吡啶基）-1,6,7,12-四（4-叔丁基苯氧基）-3,4：9,10-苝酰亚胺的合成、表征及性能研究

优化了N,N＇-二（2-吡啶基）-1,6,7,12-四（4-叔丁基苯氧基）-3,4：9,10-苝酰亚胺的合成方法,得到一种简单有效的在苝酰亚胺的酰胺和bay位置同时取代的方法.对其结构进行了表征,研究了其溶液态和薄膜态的光学性质和电化学性质.并且对其能级结构和电荷分布进行了分子模拟。     

酞菁氧钛/N,N-二甲苯基苝酰亚胺复合薄膜的光伏极性反转

用表面光电压谱和电场诱导表面光电压谱相结合的方法, 研究了酞菁氧钛/N,N-二甲苯基苝酰亚胺复合薄膜的表面光伏行为, 发现加入N,N-二甲苯基苝酰亚胺使复合薄膜在可见光区和近红外光区均产生负的光伏响应, 可归结为光伏极性反转现象. 该响应随着外加偏压方向的改变而改变正负值, 表现出表面态跃迁的特征.  根据N,N-二甲苯基苝酰亚胺n型半导体的性质,  从价带到表面态和从表面态到导带的跃迁能量的差别以及依赖于偏压方向的电场诱导表面光伏响应,  确认表面态来自N,N-二甲苯基苝酰亚胺组分.     

取代基对苝酰亚胺衍生物气敏传感性能的影响

制备了两类酰胺位置含有吸电子基团的苝酰亚胺衍生物N,N′-双(三氟乙基)-1,7-二溴-3,4,9,10-苝二酰亚胺(PTCDI-3F)和N,N′-双(七氟丁基)-1,7-二溴-3,4,9,10-苝二酰亚胺(PTCDI-7F),并测定了其气敏传感性能.结果表明,两类苝酰亚胺衍生物在水合肼气氛中(10ppm)的灵敏度变化值基本相同、电阻均降低约4个数量级.其原因在于两者具有相同的最低空轨道能级.这表明酰胺位取代基对苝酰亚胺衍生物气敏传感性能的影响较小.     

一种新型π-共轭聚合物的合成研究:苝酰亚胺的Stille偶联

苝酰亚胺衍生物是国内外近年来广泛研究的π-共轭低聚物,由于其独特的半导体传导性、高热稳定性、较高的电子亲和性和卓越的传输性能在众多领域具有潜在的应用价值。通过对其海湾位置进行结构修饰,可进一步改善其物理化学性能。本文利用苝酰亚胺的Stille偶联反应合成了一种新型的聚(N,N’-二(2-乙基己基)苝-3,4,9,10-四甲酸二酰亚胺),它具有近似石墨烯带状的规整结构和宽广的光谱吸收,成功将苝核四溴代的海湾位置用四丁基锡取代,对产品分别进行了IR、NMR和GPC-MALLS表征,并对这种具有特殊π-共轭结构的新型聚合物的光化学性能进行了研究。     

一种具有长寿命三线态的锌卟啉-苝酰亚胺超分子的光物理过程

通过吡啶基与金属锌卟啉的配位作用, 合成了一种新型卟啉-苝酰亚胺超分子配合(TPPZn-BPHPDI), 通过核磁共振氢谱确认了超分子体系的形成. 采用荧光滴定方法测得锌卟啉与苝酰亚胺配位作用的平衡常数为5.32×10⁴ L/mol. 纳秒瞬态荧光光谱和瞬态吸收光谱显示, 超分子体系内存在着从卟啉三线态向苝酰亚胺三线态的能量传递过程, 产生了寿命长达101 μs的苝酰亚胺三线态分子.     

新型苝酰亚胺衍生物的合成及其光学性能

以3,4,9,10-苝四酸二酐为原料,设计并合成了三个新型的苝酰亚胺衍生物———N,N’-二(1-戊基己基)-3,4,9,10-苝四羧酸二酰亚胺,N,N’-二(1-戊基己基)-1,6,7,12-四(对叔丁基苯氧基)-3,4,9,10-苝四羧酸二酰亚胺和N,N’-二(4-六氟异丙醇基苯基)-1,6,7,12-四(对叔丁基苯氧基)-3,4,9,10-苝四羧酸二酰亚胺,其结构经1H NMR和MS表征。用UV-Vis和荧光光谱研究了他们的光学性质。     

N-取代苝酰亚胺小分子自组装形貌及生物学应用研究进展

苝酰亚胺是具有共轭结构和发色团骨架的一类物质,分子之间存在较强π-π的相互作用.通过苝酰亚胺母核的N端引入不同的官能团对苝酰亚胺分子结构修饰,就可以很好地协调各种非共价键作用力,获得结构和功能较好的超分子组装材料和荧光发光材料,这些性质可以应用于生物学检测.本文对近些年出现的一些含有特殊结构的N-取代苝酰亚胺小分子的自...     

含三苯胺结构的非对称型苝酰亚胺的合成及性能

合成了2种含有三苯胺结构的非对称型苝酰亚胺N-(2-乙基己基)-N'-(4-三苯胺)-3,4,9,10-苝二酰亚胺(PDI-ATPA)和4,4',4″-三[N-(2-乙基己基)-3,4,9,10-苝二酰亚胺]-三苯胺(PDI-TATPA).利用核磁共振谱(NMR)、红外光谱(IR)和元素分析等方法表征了2种分子的结构,采用紫外-可见(UV-Vis)吸收光谱和荧光光谱研究了其分子光物理性能及在溶液中的聚集行为,并且对分子轨道、能级和偶极矩进行了分子模拟.研究结果表明,具有星形空间对称结构的苝酰亚胺分子PDI-TATPA在溶液中具有自组装行为;引入的三苯胺结构与苝核形成电子给体-受体结构,发生分子内电子转移(PET),进而导致荧光猝灭.     

新型三苯胺-苝酰亚胺分子阵列的合成及其光学性能

以三苯胺(1),乙二胺和3,4,9,10-苝四甲酸二酐为原料,合成了一种新型的三苯胺-苝酰亚胺分子阵列(5),其结构经~1H NMR和IR表征.用UV-Vis和荧光发射光谱研究了5的光学性能,结果表明5中发生了从三苯胺基元到苝酰亚胺基元的分子内能量转移过程.     

一种新型苝酰亚胺的合成及其与C60之间的电荷转移作用

设计和合成了一种新型苝酰亚胺电子受体—N,N ′-二嘧啶基苝四羧基二酰亚胺(DMP), 利用傅里叶红外光谱和元素分析表征了DMP的分子结构. 通过与N,N ′-二苯基-3,4,9,10-苝四羧基二酰亚胺(DPP)的循环伏安实验的对比, 证明了嘧啶基的引入降低了分子的LUMO能级. 研究了DMP与C₆₀层-层蒸镀(layer-by-layer evaporation)薄膜的荧光变化, 确认其界面处发生了由于能级位置差异导致的电荷转移.     

General diastereoselective synthetic approach toward isospongian diterpenes. Synthesis of (-)-marginatafuran, (-)-marginatone, and (-)-20-acetoxymarginatone

This work describes a synthetic approach to the carbocyclic skeleton of isospongian diterpenes that uses the commercially available monoterpene (S)-carvone as a C-ring synthon, which is incorporated into the tetracyclic isospongian framework via a C→ABC→ABCD ring annulation strategy using intramolecular Diels-Alder and ring-closing metathesis reactions. This approach has been successfully used to prepare both the title natural isospongians and several nonnatural oxygenated analogues. A preliminary evaluation of the inhibitory activity of the small collection of synthesized isospongians on the mammalian mitochondrial respiratory chain revealed that most were able to inhibit the integrated electron transfer chain (NADH oxidase activity) in the micromolar range.     

Practical synthesis of methyl(E)-2-(3-(3-(2-(7-chloro-2- quinolinyl)ethenyl)phenyl)-3-oxopropyl)benzoate,a key intermediate of Montelukast

A novel and practical synthetic route is presented for the preparation of methyl-(E)-2-(3-(3-(2-(7-chloro-2-quinolinyl)ethenyl) phenyl)-3-oxopropyl)benzoate,the key intermediate of Montelukast,a leukotriene antagonist.The main diarylpropane framework was prepared via a polarity conversation reaction resulting in an acyl anion equivalent followed by a nucleophilic substitution reaction.The overall yield of this approach was 61%.This method is simple for operation and suitable for industrial production.     

Asymmetric total syntheses of (-)-jorumycin, (-)-renieramycin G, 3-epi-jorumycin, and 3-epi-renieramycin G

The total synthesis of (-)-jorumycin (1) and (-)-renieramycin G (2) has been accomplished in 25 and 23 steps, respectively, from 5-benzyloxy-2,4-dimethoxy-3-methyl-benzyl alcohol. The synthesis features a substrate-tunable stereoselective intramolecular Pictet-Spengler-type reaction for the construction of the key pentacyclic core of both targets, bearing either the natural configuration or the epimeric configuration at C-3. With access to a C-3 epi-pentacyclic framework, 3-epi-jorumycin (32) and 3-epi-renieramycin G (34) were also successfully synthesized. Furthermore, preliminary biological evaluation of 3-epi-jorumycin (32), in addition to relevant synthetic intermediates, revealed that significant cytotoxicity had been retained in these compounds. Therefore, these early studies constitute the basis for a new structure activity relationship (SAR) investigation for this class of antitumor antibiotics.     

Synthesis of (-)-7-epiaustraline and (-)-1-epicastanospermine

Highly efficient and selective syntheses of the title compounds are described. The cornerstone of the synthetic plan is the tandem inter [4 + 2]/inter [3 + 2] cycloaddition process. These syntheses differ from previous applications of this strategy in that they incorporate an alkylation in the hydrogenolysis step to close the second ring of the azabicyclic systems. Notable features of the sequence are (1) the highly regio- and stereoselective [3 + 2] cycloaddition of nitronate 15 with siloxymethyl (Z)-beta-silylvinyl ketone (Z)-22b and (2) the highly selective reduction of the resulting ketone 24a with L-Selectride. A single-crystal X-ray structure analysis of synthetic (-)-7-epiaustraline confirmed that the targeted structure was successfully synthesized. This stimulated a reexamination of the structural assignment of the natural product. (-)-1-Epicastanospermine was synthesized in four steps from the common intermediate 27a. The absolute configuration of (-)-1-epicastanospermine was assured by single-crystal X-ray structure analysis of intermediate (-)-27a. Thus, the sign of the optical rotation had to be revised. The overall efficiency of these syntheses were 9 steps and 23% yield for (-)-7-epiaustraline and 10 steps and 20% yield for (-)-1-epicastanospermine     

A general strategy for synthesis of both (6Z)- and (6E)-cladiellin diterpenes: total syntheses of (-)-cladiella-6,11-dien-3-ol, (+)-polyanthellin A, (-)-cladiell-11-ene-3,6,7-triol, and (-)-deacetoxyalcyonin acetate

The first total synthesis of an (E)-cladiellin diterpene, (-)-cladiella-6,11-diene-3-ol (1), was accomplished featuring an intramolecular amide enolate alkylation-intramolecular Diels-Alder strategy. In addition, a highly stereo-, regio-, and chemoselective synthetic strategy for other members of the cladiellin diterpenes such as (+)-polyanthellin A (2), (-)-cladiell-11-ene-3,6,7-triol (3), and (-)-deacetoxyalcyonin acetate (4) was developed utilizing the synthetic (E)-cladiellin 1 as a common intermediate by taking advantage of the unique chemical properties of its C(6)-(E)-oxatricyclic skeleton.     

Novel (E)- and (Z)-3(5)-(2-hydroxyphenyl)-4-styrylpyrazoles from (E)- and (Z)-3-styrylchromones: the unexpected case of (E)-3(5)-(2-hydroxyphenyl)-4-(4-nitrostyryl)pyrazoles

An efficient synthetic method for the preparation of (E)- and (Z)-3(5)-(2-hydroxyphenyl)-4-styrylpyrazoles has been developed. The reaction of (E)- and (Z)-3-styrylchromones with hydrazine hydrate afforded the corresponding (E)- and (Z)-4-styrylpyrazoles, respectively, saved 4′-nitro-derivatives where both (E)- and (Z)-4′-nitro-3-styrylchromones afforded (E)-3(5)-(2-hydroxyphenyl)-4-(4-nitrostyryl)pyrazoles. The reaction mechanism for these transformations was discussed and the stereochemistry of all products was assigned by NMR experiments.     

First Enantioselective Synthesis of (2R,3R)-and(2S,3S)-2-(4-hydroxyphenyl)-3-hydroxymethyl-1,4-benzodioxan-6-carbaldehyde

Numerous lignans containing 1,4-benzodioxane nucleus represent a class of natural products with cytotoxic and hepatoprotective activities1,2. Recently we have reported the racemic total synthesis of sinaiticin, a flavonolignan of the 1,4-benzodioxane type which was isolated from sinaiticum leaves found in sinai region of Egypt, using 2-(4-hydroxyphenyl)-3-hydroxymethyl-1,4-benzodioxan-6-carbaldehyde as the key interme-diate3,4. This species exhibits significant inhibitory activity against the …     

A stereodivergent strategy for the preparation of corynantheine and ipecac alkaloids, their epimers, and analogues: efficient total synthesis of (-)-dihydrocorynantheol, (-)-corynantheol, (-)-protoemetinol, (-)-corynantheal, (-)-protoemetine, and related natural and nonnatural compounds

Here we present a general and common catalytic asymmetric strategy for the total and formal synthesis of a broad number of optically active natural products from the corynantheine and ipecac alkaloid families, for example, indolo[2,3-a]- and benzo[a]quinolizidines. Construction of the core alkaloid skeletons with the correct absolute and relative stereochemistry relies on an enantioselective and diastereodivergent one-pot cascade sequence followed by an additional diastereodivergent reaction step. This allows for enantio- and diastereoselective synthesis of three out of four possible epimers of the quinolizidine alkaloids that begin from common and easily accessible starting materials by using a common synthetic route. Focus has been made on excluding protecting groups and limiting isolation and purification of synthetic intermediates. This methodology is applied in the total synthesis of the natural products (-)-dihydrocorynantheol, (-)-hirsutinol, (-)-corynantheol, (-)-protometinol, (-)-dihydrocorynantheal, (-)-corynantheal, (-)-protoemetine, (-)-(15S)-hydroxydihydrocorynantheol, and an array of their nonnatural epimers. The potential of this strategy is also demonstrated in the synthesis of biologically interesting natural product analogues not accessible through synthetic elaboration of alkaloid precursors available from nature, for example, thieno[3,2-a]quinolizidine derivatives. We also report the formal synthesis of (+)-dihydrocorynantheine, (-)-emetine, (-)-cephaeline, (-)-tubulosine, and (-)-deoxytubulosine.     

Synthesis of enantiopure (R,R)- and (S,S)-cis-2,3-propanoprolines

A novel approach to the synthesis of an enantiopure bicyclic proline analogue, hexahydrocyclopenta[b]pyrrole-6a(1H)-carboxylic acid (‘2,3-propanoproline’), has been developed. The method relied on tandem Strecker-nucleophilic cyclization reaction of 2-(2-bromoethyl)cyclopentanone. The overall synthetic scheme included six steps and resulted in 18% overall yield of both enantiomers of the title amino acid.     

A practical procedure for the synthesis of esonarimod, (R,S)-2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid,an antirheumatic agent (part 1)

An efficient and practical procedure for the synthesis of esonarimod, (R,S)-2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (1), a new antirheumatic drug, has been developed. The intermediate, 2-methylene-4-(4-methylphenyl)-4-oxobutanoic acid (2), was prepared by Friedel-Crafts acylation of toluene with itaconic anhydride (3) in the presence of aluminum trichloride and nitrobenzene in 63% yield without silica gel column purification. Compound 1 was prepared by Michael addition of 2 with thioacetic acid (4) in 74% yield. Overall, 1 was obtained in 47% yield from 3. The structures and synthetic mechanisms of by-products (five compounds) of 2 were also clarified.